Pharmacoepidemiology, Infectious Diseases, Pharmaceutical Policy, Vaccine Policy
Andrew Wiese is an Assistant Professor in the Department of Health Policy at the Vanderbilt University School of Medicine. Dr. Wiese is a pharmacoepidemiologist whose research aims to leverage observational studies to provide real-world evidence of the safety and efficacy of commonly used medications and vaccines. His current work is focused on characterizing the safety of medication use among women during pregnancy and in the postpartum period, assessing the efficacy and safety of pharmacological agents for the treatment of Type 2 Diabetes, and evaluating the ongoing impact of pneumococcal conjugate vaccine introduction in the US.
Dr. Wiese is a current BIRWCH (Building Interdisciplinary Research Careers in Women’s Health) K12 Scholar and a former Vanderbilt Faculty Research Scholar. Dr. Wiese completed his postdoctoral training in the Department of Health Policy at the Vanderbilt University School of Medicine and is the former recipient of a PhRMA Foundation Postdoctoral Fellowship in Health Outcomes. Dr. Wiese obtained his MPH from Saint Louis University, his PhD in Epidemiology from Vanderbilt University, and is a former CDC/CSTE Applied Epidemiology Fellow in the Healthcare-Associated Infections Program at the Tennessee Department of Health.